cyclosporine has been researched along with Liver Neoplasms in 89 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 30 (33.71) | 18.2507 |
2000's | 39 (43.82) | 29.6817 |
2010's | 16 (17.98) | 24.3611 |
2020's | 4 (4.49) | 2.80 |
Authors | Studies |
---|---|
Bae, S; Cho, Y; Choi, J; Kang, JA; Kim, YC; Lee, D; Lim, C; Park, M; Park, SG; Seo, J | 1 |
Abo-El Fetoh, ME; Akool, ES; Elnagar, MR; ElShafey, M; Ewees, M; Helal, GK; Saleh, IG | 1 |
Chen, YJ; Hsieh, CH; Huang, HL; Huang, YC; Tai, HC; Tsai, TH; Wang, LY | 1 |
Bharathi, G; Fan, H; Gao, S; Li, W; Li, Y; Meng, F; Wang, C; Wang, L; Yang, Y; Zhou, Y | 1 |
González-Diéguez, ML; Houghton, RF; Mendoza Pacas, GE; Viso Vidal, D | 1 |
Gow, PJ; Grigg, SE; Sarri, GL; Yeomans, ND | 1 |
Dansako, H; Gu, W; Kato, N; Nishitsuji, H; Satoh, S; Shimotohno, K; Ueda, Y | 1 |
Bian, XL; Du, Q; Xu, XL; Yu, B; Zhai, Q; Zhu, B | 1 |
Fan, H; Gu, L; Jin, W; Kan, L; Shan, C; Wang, X | 1 |
Chen, J; Chen, S; Gong, Z; Jiang, S; Li, L; Wang, J; Wei, Y; Yu, L; Zhang, M; Zhang, Y; Zhao, X | 1 |
Basu, A; Briscoe, DM; Cohen, HT; Contreras, AG; Datta, D; Flynn, E; Pal, S; Zeng, L | 1 |
Cucchetti, A; Del Gaudio, M; Grazi, GL; La Barba, G; Lauro, A; Pinna, AD; Ravaioli, M; Vivarelli, M | 1 |
Dai, QS; Guo, QL; Hu, R; Liu, W; Lu, N; Mu, R; Nie, FF; Qi, Q; Rong, JJ; Wang, J; Wang, XT; Yang, Y; You, QD | 1 |
de Alaniz, MJ; de Gómez Dumm, IN; Lausada, N; Raimondi, JC | 1 |
Ling, XL; Zhou, Y | 1 |
Bai, Z; Du, X; Han, Y; Huan, T; Liu, L; Wang, Z; Wu, B; Zhang, J | 1 |
Lee, J | 1 |
Li, SW; Ling, X; Wen, L; Yan, B; Zhou, Y | 1 |
Ballarin, R; Cautero, N; Cocchi, S; Codeluppi, M; D'Amico, G; De Ruvo, N; Di Benedetto, F; Gerunda, GE; Guaraldi, G; Guerrini, GP; Iemmolo, RM; Mimmo, A; Montalti, R; Rompianesi, G; Serra, V; Smerieri, N; Spaggiari, M; Tarantino, G | 1 |
Cai-Hong, Z; Fang, M; Jin-Hua, J; Li, H; Ning, W; Qing-Duan, W; Xiao-Juan, G; Yan, Z | 1 |
Jeon, YJ; Kim, YS | 1 |
Dong, C; He, M; Ren, R; Shao, C; Xie, Y; Ye, S; Yuan, D | 1 |
Goto, T; Koike, K; Kurokawa, M; Yamamoto, G; Yoshimi, A | 1 |
Alvarez Castro, AM; Castroagudín, JF; Molina Pérez, E; Seijo Ríos, S; Varo Pérez, E | 1 |
Lang, F; Loupatatzis, C; Schönfeld, P; Seitz, G; Siemen, D | 1 |
Caro, AA; Cederbaum, AI | 1 |
Deschênes, G; Landman-Parker, J; Lucidarme, N; Nathanson, S | 1 |
Aden, AA; Bellusci, R; Brillanti, S; Cavallari, A; Cavrini, G; Cucchetti, A; De Ruvo, N; La Barba, G; Vivarelli, M | 1 |
Chi, CW; Lin, HL; Liu, TY; Lui, WY | 1 |
Beath, SV; de Ville de Goyet, J; Grundy, R; Kelly, DA; Lee, WS; McKiernan, PJ; Milford, DV; Taylor, CM | 1 |
Jiang, GP; Li, MW; Xie, HY; Yang, FC; Zeng, QL; Zheng, SS | 1 |
Kang, YS; Kim, JA; Lee, YS | 1 |
Kido, H; Miyake, H; Okumura, Y; Sakai, M; Tashiro, S | 1 |
Burdelski, MM | 1 |
Jeon, YS; Jeong, ES; Kim, EK; Kim, KS; Kwon, KB; Lim, JG; Ryu, DG; Seo, EA; Shin, BC | 1 |
Bolondi, L; Cavallari, A; Cucchetti, A; La Barba, G; Pinna, AD; Piscaglia, F; Vivarelli, M | 1 |
Casadio, F; Corti, B; Croci, S; D'Errico Grigioni, A; Grigioni, WF; Landuzzi, L; Lollini, PL | 1 |
Broyles, RH; Floyd, RA; Guo, WX; Hensley, KL; Kotake, Y; Pye, QN; Stewart, CA; Williamson, KS | 1 |
Brunati, A; Cerutti, E; David, E; Franchello, A; Gennari, F; Lavezzo, B; Lupo, F; Marzano, A; Ottobrelli, A; Ricchiuti, A; Rizzetto, M; Romagnoli, R; Salizzoni, M; Schellino, MM; Strignano, P; Zamboni, F | 1 |
Cederbaum, AI; Zhuge, J | 1 |
Borel Rinkes, IH; Hoeben, RC; Kranenburg, O; Smakman, N; van den Wollenberg, DJ; van der Bilt, JD | 1 |
Shen, Y; Wu, LM; Xia, WL; Xie, HY; Zhang, F; Zheng, SS | 1 |
Kobayashi, E; Murakami, T; Ohsawa, I; Uemoto, S | 2 |
Huang, YF; Li, LS; Li, Y; Liu, FY; Liu, ZH; Peng, YM | 1 |
Demirhan, B; Haberal, M; Kiyici, H; Nacar, A; Oğüş, E; Ozdemir, H; Zağyapan, R | 1 |
Cillo, U; Grazi, GL; Lake, J; Leonardi, L; Levy, G; Mies, S; Mühlbacher, F; Munn, S; Rossi, M; Samuel, D; Sanjuan, F; Villamil, F | 1 |
Li, L; Zhang, YM; Zhu, ZJ | 1 |
Bouchard, MJ; Clippinger, AJ; Lizzano, R; McClain, SL | 1 |
Bak, T; Campsen, J; Kam, I; Skibba, A; Trotter, JF; Wachs, M; Zimmerman, MA | 1 |
Li, D; Ma, CP; Qu, B; Sun, LH; Wan, J; Wang, W; Zhang, HQ; Zhang, SS | 1 |
Bismuth, H | 1 |
Ament, ME; Busuttil, RW; McDiarmid, SV; Vargas, J; Wallace, P | 1 |
Kaplan, MM; Pedrosa, MC; Rohrer, RM | 1 |
Ascher, NL; Ferrell, LD; Hebert, M; Lake, JR; Nikolai, B; Roberts, JP | 1 |
Lipkowitz, GS; Madden, RL | 1 |
Charlotte, F; Cherqui, D; Duvoux, C; Fagniez, PL; Humeres, R; Julien, M; Lauzet, JY; Métreau, JM; Rotman, N; Salvat, A | 1 |
Eramishantsev, AK; Goté, SV; Konstantinov, BA; Lebezev, VM; Lokshin, LS; Shertsinger, AG; Skipenko, OG; Tsirulńikova, OM | 1 |
Andreola, S; Bertuzzi, F; Colella, G; Damascelli, B; Maffi, P; Magistretti, P; Mazzaferro, V; Mirenda, V; Regalia, E; Socci, C | 1 |
de Wit, EC; Kaptein, A; Princen, HM | 1 |
Bosi, A; Grossi, A; Guidi, S; Rafanelli, D; Rossi-Ferrini, P; Saccardi, R; Statello, M; Vannucchi, AM | 1 |
Choi, JH; Chung, JB; Kim, BS; Kim, HS; Kim, JH; Kwon, OH; Lee, KS; Park, IS; Roh, JK; Yoo, NC | 1 |
Chen, CS; Chen, TC; Chu, SH; Huang, CC; Jeng, LB; Lai, MK | 1 |
Florén, CH; Rayyes, OA; Wallmark, A | 1 |
Bagga, S; Gupta, SM; Johns, W | 1 |
Berg, T; Fukomoto, T; Haller, GW; Hopf, U; Lemmens, HP; Lobeck, H; Mueller, AR; Naumann, U; Neuhaus, P; Platz, KP | 1 |
Bechstein, WO; Berg, T; Fukomoto, T; Guckelberger, O; Hopf, U; Lobeck, H; Mueller, AR; Neuhaus, P; Neuhaus, R; Platz, KP | 1 |
Bechstein, WO; Guckelberger, O; Jonas, S; Lobeck, H; Neuhaus, P; Neuhaus, R; Rayes, N; Riess, H; Schmidt, G; Tullius, SG; Vogl, T | 1 |
Hebert, D; Reid, CJ | 1 |
Oya, S; Vaquero, J; Zurita, M | 1 |
Köhler, H; Krüger, B; Riegel, W; Ulrich, C | 1 |
Fragulidis, GP; Kato, T; Khan, MF; Miller, J; Nery, JR; Pinna, AD; Reddy, KR; Torres, MB; Tzakis, AG; Weppler, D; Zervos, XA | 1 |
Born, G; Froschauer, R; Gralka, S; Hohenberger, W; Köckerling, F; Müller, V; Ott, R; Reck, T | 1 |
Bechstein, WO; Jonas, S; Naumann, U; Neuhaus, P; Neuhaus, R; Nüssler, NC; Rayes, N; Serke, S; Tullius, SG | 1 |
Goldstein, R; Klintmalm, G; Mues, G; Stone, MJ; Su, D; Tillery, GW; Tong, AW | 1 |
Fandrey, J; Jelkmann, W; Wördemann, M | 1 |
Hoek, JB; Pastorino, JG | 1 |
Berr, F; Hartwig, T; Hauss, J; Kohlhaw, K; Lübke, P; Schwarz, R | 1 |
Morrow, CS; Smitherman, PK; Townsend, AJ | 1 |
Ding, WX; Liu, J; Ong, CN; Shen, HM; Yang, CF | 1 |
Arenas, JI; García Bengoechea, M; Indart, A | 1 |
Andreola, S; Bertuzzi, F; Bozzetti, F; Di Bartolomeo, M; Di Carlo, V; Doci, R; Gennari, L; Mazzaferro, V; Pozza, G; Regalia, E; Socci, C | 1 |
DePierre, JW; Grandér, D; Panaretakis, T; Shabalina, IG; Shoshan, MC | 1 |
Fujiwara, A; Mouri, H; Ogawa, S; Ohta, T; Sakaguchi, K; Sawayama, T; Senoh, T; Shiraga, K; Tsuji, T | 1 |
Brown, AJ; Lyons, MA | 1 |
Hardy, KJ; Phillips, PA; Potocnik, SJ | 1 |
Greig, PD; Moody, AR; Wilson, SR | 1 |
Chrétien, Y; Nordlinger, B; Panis, Y; Ribeiro, J | 1 |
Appelkvist, EL; Bäckman, L; Brunk, U; Sundberg, A; Teclebrhan, H | 1 |
5 review(s) available for cyclosporine and Liver Neoplasms
Article | Year |
---|---|
Multiple hepatocellular adenomas associated with long-term administration of androgenic steroids for aplastic anemia: A case report and literature review.
Topics: Abdominal Pain; Adenoma, Liver Cell; Adolescent; Adult; Aftercare; Aged; Anemia, Aplastic; Biopsy, Fine-Needle; Cyclosporine; Diagnostic Errors; Female; Fever; Humans; Immunosuppressive Agents; Liver Abscess; Liver Neoplasms; Male; Middle Aged; Shock, Hemorrhagic; Stanozolol; Testosterone Congeners; Tomography, X-Ray Computed | 2020 |
Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
Topics: Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Everolimus; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2019 |
Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chronic Disease; Combined Modality Therapy; Cyclosporine; Embolization, Therapeutic; Esophageal and Gastric Varices; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Chronic-Phase; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Postoperative Complications; Prednisolone | 2012 |
[Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
Topics: Adult; Aged; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Hepatitis; Humans; Immune Tolerance; Immunosuppression Therapy; Incidence; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Prospective Studies | 1994 |
[Clinical studies in liver transplantation].
Topics: Carcinoma, Hepatocellular; Cyclosporine; Cytomegalovirus Infections; Double-Blind Method; Hepatitis B; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Multicenter Studies as Topic; Postoperative Complications; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Tacrolimus | 2000 |
5 trial(s) available for cyclosporine and Liver Neoplasms
Article | Year |
---|---|
A retrospective study to compare the use of tacrolimus and cyclosporine in combination with adriamycin in post-transplant liver cancer patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cyclosporine; Doxorubicin; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Tacrolimus | 2015 |
Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Female; Follow-Up Studies; Hepatitis C; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Li
Topics: Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Incidence; Liver Diseases; Liver Neoplasms; Liver Transplantation; Male; Steroids; Survival Rate; Tacrolimus | 1995 |
The treatment of intractable rejection with tacrolimus (FK506) in pediatric liver transplant recipients.
Topics: Administration, Oral; Bilirubin; Child; Child, Preschool; Cyclosporine; Graft Rejection; Humans; Immunosuppression Therapy; Infant; Kidney; Liver; Liver Neoplasms; Liver Transplantation; Lymphoma, B-Cell; Prednisone; Tacrolimus | 1995 |
Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation.
Topics: Adult; Aged; Cyclosporine; Female; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Neoplasms; Male; Methylprednisolone; Middle Aged; Recurrence; RNA, Viral; Tacrolimus | 1998 |
79 other study(ies) available for cyclosporine and Liver Neoplasms
Article | Year |
---|---|
Entry inhibition of hepatitis B virus using cyclosporin O derivatives with peptoid side chain incorporation.
Topics: Antiviral Agents; Cyclosporins; Hepatitis B; Hepatitis B virus; Humans; Imidazoles; Liver Neoplasms; Organic Anion Transporters, Sodium-Dependent; Peptoids; Sulfonamides; Symporters; Thiophenes; Virus Internalization | 2022 |
Cyclosporin A activates human hepatocellular carcinoma (HepG2 cells) proliferation: implication of EGFR-mediated ERK1/2 signaling pathway.
Topics: ADAM17 Protein; Carcinoma, Hepatocellular; Cell Proliferation; Cyclosporine; Enzyme Activation; ErbB Receptors; Hep G2 Cells; Humans; Immunosuppressive Agents; Liver Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Reactive Oxygen Species; Signal Transduction | 2020 |
Robust combination of liver stereotactic body radiotherapy modulates pharmacokinetics of sorafenib toward preferable parameters.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Carcinoma, Hepatocellular; Cell Line, Tumor; Combined Modality Therapy; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Radiation; Enzyme Induction; Humans; Liver Neoplasms; Male; NF-kappa B; Portal Vein; Protein Kinase Inhibitors; Radiosurgery; Rats; Rats, Sprague-Dawley; Retrospective Studies; Sorafenib; Specific Pathogen-Free Organisms; Tissue Distribution; Venous Thrombosis | 2020 |
Tacrolimus-Induced Cholestatic Hepatitis in a Patient With Liver Transplant.
Topics: Allografts; Biopsy; Carcinoma, Hepatocellular; Cholestasis; Cyclosporine; Graft Rejection; Hepatitis; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Tacrolimus; Ultrasonography, Doppler | 2018 |
A new hepatoma cell line exhibiting high susceptibility to hepatitis B virus infection.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclosporine; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Host-Pathogen Interactions; Humans; Liver Neoplasms; Organic Anion Transporters, Sodium-Dependent; Rosiglitazone; Symporters; Virus Internalization | 2019 |
Role of mitochondrial permeability transition in human hepatocellular carcinoma Hep-G2 cell death induced by rhein.
Topics: Adenosine Triphosphate; Anthraquinones; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cyclosporine; Cytochromes c; Hep G2 Cells; Humans; In Situ Nick-End Labeling; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Permeability; Phytotherapy; Plant Extracts; Rheum | 2013 |
Cyclophilin J is a novel peptidyl-prolyl isomerase and target for repressing the growth of hepatocellular carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Chlorocebus aethiops; COS Cells; Cyclin D1; Cyclophilins; Cyclosporine; G1 Phase; Gene Expression Regulation, Neoplastic; HEK293 Cells; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Protein Structure, Tertiary; S Phase; Up-Regulation; Xenograft Model Antitumor Assays | 2015 |
Overexpression of vascular endothelial growth factor and the development of post-transplantation cancer.
Topics: Animals; Calcineurin Inhibitors; Cell Line, Tumor; Cyclosporine; Gene Expression Regulation, Neoplastic; Humans; Immunosuppressive Agents; Liver Neoplasms; Mice; Mice, Inbred BALB C; Models, Biological; Neoplasm Transplantation; Neovascularization, Pathologic; Organ Transplantation; Vascular Endothelial Growth Factor A | 2008 |
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
Topics: Adult; alpha-Fetoproteins; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Risk Factors; ROC Curve; Sensitivity and Specificity; Tacrolimus | 2008 |
MAC-related mitochondrial pathway in oroxylin-A-induced apoptosis in human hepatocellular carcinoma HepG2 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclosporine; Dimerization; Flavonoids; Humans; Ion Channels; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Neoplasm Proteins; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; RNA Interference; RNA, Small Interfering | 2009 |
Effect of cyclosporine and sirolimus on fatty acid desaturase activities in cultured HEPG2 cells.
Topics: Arachidonic Acids; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclosporine; Fatty Acid Desaturases; Fatty Acids; Humans; Immunosuppressive Agents; Kinetics; Linoleic Acid; Liver Neoplasms; Palmitic Acid; Sirolimus | 2009 |
Establishment of a cisplatin-induced multidrug resistance cell line SK-Hep1/DDP.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclosporine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorouracil; Humans; Liver Neoplasms; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Vincristine | 2010 |
Prolonged survival of human hepatocarcinoma cells in the liver of newborn C57BL/6 mice and resulting cellular xenorejection, especially the activation of hepatic natural killer T cells.
Topics: Age Factors; Animals; Animals, Newborn; Antigens, CD1d; Apoptosis; Carcinoma, Hepatocellular; CD3 Complex; Cell Survival; Cyclosporine; Graft Survival; Hep G2 Cells; Humans; Immunity, Cellular; Immunosuppressive Agents; Interferon-gamma; Interleukin-4; Liver; Liver Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Mice; Mice, Inbred C57BL; Natural Killer T-Cells; Neoplasm Transplantation; Spleen; Time Factors; Transplantation, Heterologous; Tumor Escape | 2010 |
Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cisplatin; Cyclophilin A; Cyclosporine; Drug Resistance, Neoplasm; Drug Synergism; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Lactones; Liver Neoplasms; Oxidative Stress; Reactive Oxygen Species; Spiro Compounds; Tumor Suppressor Protein p53; Up-Regulation | 2010 |
Modulation of mitochondrial permeability transition pore affects multidrug resistance in human hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Atracurium; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Cisplatin; Cyclosporine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Microscopy, Confocal; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore | 2010 |
University of Modena experience in HIV-positive patients undergoing liver transplantation.
Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Cyclosporine; Drug Substitution; End Stage Liver Disease; Female; Graft Rejection; Graft Survival; Hepatitis C, Chronic; HIV; HIV Infections; Hospitals, University; Humans; Immunosuppressive Agents; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Severity of Illness Index; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome; Viral Load | 2011 |
Using rhodamine 123 accumulation in CD8 cells as a surrogate indicator to study the P-glycoprotein modulating effect of cepharanthine hydrochloride in vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Carcinoma, Hepatocellular; CD8-Positive T-Lymphocytes; Cyclosporine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Dyes; Fluorouracil; Humans; Indicators and Reagents; Liver Neoplasms; Mice; Rhodamine 123; Tumor Cells, Cultured; Verapamil; Xenograft Model Antitumor Assays | 2011 |
Cyclosporin a inhibits albumin synthesis in Huh7 cells.
Topics: Blotting, Northern; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Culture Media, Conditioned; Cyclosporine; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Humans; Hypoalbuminemia; Immunosuppressive Agents; Liver Neoplasms; RNA, Messenger; Serum Albumin; Time Factors | 2011 |
Cytochrome-c mediated a bystander response dependent on inducible nitric oxide synthase in irradiated hepatoma cells.
Topics: Bystander Effect; Carcinoma, Hepatocellular; Cell Line, Tumor; Coculture Techniques; Cyclosporine; Cytochromes c; Gamma Rays; Hep G2 Cells; Humans; Isothiuronium; Liver Neoplasms; Micronucleus Tests; Nitric Oxide; Nitric Oxide Synthase Type II; Reactive Oxygen Species; Signal Transduction | 2012 |
[Basiliximab in the treatment of acute steroid-resistant rejection after liver transplantation].
Topics: Acute Disease; Antibodies, Monoclonal; Basiliximab; Carcinoma, Hepatocellular; Cyclosporine; Drug Resistance; Graft Rejection; Humans; Immunosuppressive Agents; Liver Cirrhosis, Alcoholic; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pregnenediones; Receptors, Interleukin-2; Recombinant Fusion Proteins; Tacrolimus | 2012 |
Single-channel currents of the permeability transition pore from the inner mitochondrial membrane of rat liver and of a human hepatoma cell line.
Topics: Animals; Apoptosis; Calcium; Carcinoma, Hepatocellular; Cyclosporine; Dose-Response Relationship, Drug; Electrophysiology; fas Receptor; Humans; Intracellular Membranes; Ion Channels; Jurkat Cells; Liver Neoplasms; Membrane Potentials; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Patch-Clamp Techniques; Rats; Tumor Cells, Cultured | 2002 |
Ca2+-dependent and independent mitochondrial damage in HepG2 cells that overexpress CYP2E1.
Topics: alpha-Tocopherol; Arachidonic Acid; Calcium; Calpain; Carcinoma, Hepatocellular; Culture Media; Cyclosporine; Cysteine Proteinase Inhibitors; Cytochrome P-450 CYP2E1; Cytosol; Dipeptides; Humans; Intracellular Membranes; Iron; Lipid Peroxidation; Liver Neoplasms; Mitochondria, Liver; Oxidative Stress; Permeability; Tumor Cells, Cultured | 2002 |
Long-term survival of renal graft complicated with Burkitt lymphoma.
Topics: Antimetabolites, Antineoplastic; Burkitt Lymphoma; Creatinine; Cyclosporine; Cytarabine; Graft Survival; Humans; Immunosuppressive Agents; Infant; Kidney Neoplasms; Kidney Transplantation; Liver Neoplasms; Male; Nephrotic Syndrome; Splenic Neoplasms | 2002 |
Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?
Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Postoperative Complications; Retrospective Studies; Risk Factors; Survival Rate | 2002 |
Reversal of Taxol resistance in hepatoma by cyclosporin A: involvement of the PI-3 kinase-AKT 1 pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Flow Cytometry; Humans; Liver Neoplasms; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, SCID; Mitochondria; Paclitaxel; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tumor Cells, Cultured | 2003 |
Renal function following liver transplantation for unresectable hepatoblastoma.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Female; Glomerular Filtration Rate; Hepatoblastoma; Humans; Immunosuppressive Agents; Infant; Kidney; Liver Neoplasms; Liver Transplantation; Male; Postoperative Period | 2003 |
[Influence of combined cyclosporine A and tacrolimus with 5-fluorouracil on hepatocellular carcinoma rats].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cyclosporine; Fluorouracil; Liver Neoplasms; Male; Membrane Potentials; Mitochondria; Necrosis; Rats; Rats, Wistar; Tacrolimus | 2003 |
Role of Ca2+-activated Cl- channels in the mechanism of apoptosis induced by cyclosporin A in a human hepatoma cell line.
Topics: Apoptosis; Calcium; Cell Count; Chloride Channels; Chlorine; Cyclosporine; Dose-Response Relationship, Drug; Hepatoblastoma; Humans; Ion Channel Gating; Liver Neoplasms; Tumor Cells, Cultured | 2003 |
Inhibitory effect of FK506 and cyclosporine A on the growth and invasion of human liver cancer cells.
Topics: Carcinoma, Hepatocellular; Cell Division; Cell Line, Tumor; Cyclosporine; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Liver Neoplasms; Neoplasm Invasiveness; Tacrolimus | 2004 |
The impact of cyclosporine on the development of immunosuppressive therapy for pediatric liver transplantation.
Topics: Acute Disease; Child; Chronic Disease; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Liver Neoplasms; Retrospective Studies; Survival Analysis | 2004 |
Molecular mechanisms of apoptosis induced by Scorpio water extract in human hepatoma HepG2 cells.
Topics: Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase 9; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cyclosporine; Cysteine Proteinase Inhibitors; Cytochromes c; Drugs, Chinese Herbal; Enzyme Inhibitors; Humans; Liver Neoplasms; Membrane Potentials; Mitochondria; Oligopeptides; Poly(ADP-ribose) Polymerases | 2005 |
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Disease-Free Survival; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasm Recurrence, Local; Risk Factors; ROC Curve | 2005 |
Toward the definition of immunosuppressive regimens with antitumor activity.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Jurkat Cells; Leflunomide; Liver Neoplasms; Mycophenolic Acid; Rhabdomyosarcoma; Sirolimus | 2005 |
Mitochondrial dysfunction in choline deficiency-induced apoptosis in cultured rat hepatocytes.
Topics: Animals; Apoptosis; Benzyl Compounds; Blotting, Western; Caspases; Cell Separation; Cells, Cultured; Choline; Cyclosporine; DNA Fragmentation; Electron Transport; Enzyme Inhibitors; Flow Cytometry; Free Radicals; Hepatocytes; Hydrocarbons, Fluorinated; Liver Neoplasms; Membrane Potentials; Mitochondria; Rats; Reactive Oxygen Species; Rotenone; Time Factors | 2005 |
The first one thousand liver transplants in Turin: a single-center experience in Italy.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Child; Child, Preschool; Cyclosporine; Fibrosis; Graft Survival; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Italy; Liver Neoplasms; Liver Transplantation; Middle Aged; Models, Statistical; Time Factors; Treatment Outcome | 2005 |
Serum deprivation-induced HepG2 cell death is potentiated by CYP2E1.
Topics: Antidotes; Antioxidants; Apoptosis; Chromans; Culture Media, Serum-Free; Cyclosporine; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP2E1 Inhibitors; DNA, Neoplasm; Enzyme Inhibitors; Flow Cytometry; Fomepizole; Glutathione; Humans; Lipid Peroxidation; Liver Neoplasms; Membrane Potentials; Mitochondria; Pyrazoles; Reactive Oxygen Species; Tumor Cells, Cultured | 2006 |
Immunosuppression promotes reovirus therapy of colorectal liver metastases.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Combined Modality Therapy; Cyclosporine; Immunosuppressive Agents; Injections, Intralesional; Liver Neoplasms; Mammalian orthoreovirus 3; Mice; Mice, Inbred BALB C; Mutation; Oncolytic Virotherapy; Oncolytic Viruses; Transplantation, Isogeneic; Xenograft Model Antitumor Assays | 2006 |
[Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study].
Topics: Cell Line, Tumor; Cell Survival; Cyclosporine; Enzyme-Linked Immunosorbent Assay; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Liver Neoplasms; Tacrolimus; Transfection; Virus Replication | 2006 |
In vivo luminescent imaging of cyclosporin A-mediated cancer progression in rats.
Topics: Adenocarcinoma; Animals; Benzamides; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Cyclosporine; Dioxoles; Disease Progression; Gene Expression Regulation, Neoplastic; Image Processing, Computer-Assisted; Killer Cells, Natural; Liver Neoplasms; Luminescence; Lymphatic Metastasis; Male; Neoplasm Metastasis; Rats; Rats, Inbred F344; Receptors, Chemokine; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
[Effects of tacrolimus and cyclosporine on albumin secretion in cultured human hepatocyte].
Topics: Albumins; Carcinoma, Hepatocellular; Cyclosporine; Hepatocytes; Humans; Interleukin-10; Interleukin-2; Interleukin-6; Liver Neoplasms; Tacrolimus; Tumor Cells, Cultured | 2006 |
Ultrastructural examination of glomerular and tubular changes in renal allografts with cyclosporine toxicity.
Topics: Adult; Carcinoma, Hepatocellular; Case-Control Studies; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Liver Neoplasms; Male; Retrospective Studies; Transplantation, Homologous | 2006 |
[Diagnosis and treatment of de novo malignancy after liver transplantation].
Topics: Adult; Antiviral Agents; Colonic Neoplasms; Cyclosporine; Esophageal Neoplasms; Female; Ganciclovir; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Lymphoproliferative Disorders; Middle Aged; Pharyngeal Neoplasms; Survival Analysis; Tacrolimus; Time Factors | 2007 |
Hepatitis B virus replication is associated with an HBx-dependent mitochondrion-regulated increase in cytosolic calcium levels.
Topics: Calcium; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclosporine; Cytosol; DNA, Viral; Gene Expression Regulation; Gene Expression Regulation, Viral; Genome, Viral; Hepatitis B Antigens; Hepatitis B virus; Humans; Liver Neoplasms; Mitochondria; Virus Replication | 2007 |
Control of cyclosporine A-induced tumor progression using 15-deoxyspergualin for rat cardiac transplantation.
Topics: Animals; Caspase 3; Caspase 7; Cell Proliferation; Colonic Neoplasms; Cyclosporine; Disease Progression; Graft Survival; Guanidines; Heart; Heart Transplantation; Immunosuppressive Agents; Liver; Liver Neoplasms; Luciferases; NF-kappa B; Rats; Rats, Inbred F344; Rats, Inbred Lew | 2007 |
Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Neoplasm Recurrence, Local; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2008 |
A novel benzotriazole derivative inhibits proliferation of human hepatocarcinoma cells by increasing oxidative stress concomitant mitochondrial damage.
Topics: Antineoplastic Agents; Antioxidants; Ascorbic Acid; Carcinoma, Hepatocellular; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria, Liver; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Reactive Oxygen Species; Time Factors; Triazoles | 2008 |
Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholangitis, Sclerosing; Cushing Syndrome; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prednisone | 1995 |
Reversal of chronic rejection after treatment failure with FK506 and RS61443.
Topics: Adult; Carcinoma, Hepatocellular; Cyclosporine; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Function Tests; Liver Neoplasms; Liver Transplantation; Muromonab-CD3; Mycophenolic Acid; Tacrolimus | 1993 |
Transmission of Kaposi's sarcoma by solid organ donation.
Topics: Adult; Azathioprine; Cyclosporine; Disease Transmission, Infectious; Fatal Outcome; Female; Follow-Up Studies; Humans; Kidney Transplantation; Liver Neoplasms; Liver Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Sarcoma, Kaposi; Skin Neoplasms; Tissue Donors | 1994 |
[Orthotopic liver transplantation (first clinical experience)].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Carcinoma, Hepatocellular; Child; Cyclosporine; Female; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Liver Diseases; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Reoperation; Time Factors | 1993 |
Insulin independence after islet-liver transplantation for metastatic neuroendocrine pancreatic tumor.
Topics: Cyclosporine; Glucose Tolerance Test; Humans; Immunosuppression Therapy; Insulin; Islets of Langerhans Transplantation; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neuroendocrine Tumors; Pancreatectomy; Pancreatic Neoplasms | 1994 |
Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2.
Topics: Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Carcinoma, Hepatocellular; Cyclosporine; Humans; Liver Neoplasms; Protein Biosynthesis; RNA, Messenger; Serum Albumin; Tumor Cells, Cultured | 1994 |
Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line.
Topics: Amino Acid Isomerases; Carcinoma, Hepatocellular; Carrier Proteins; Cyclosporine; Dose-Response Relationship, Drug; Erythropoietin; Gene Expression; Humans; In Vitro Techniques; Liver; Liver Neoplasms; Peptidylprolyl Isomerase; Protein Biosynthesis; RNA, Messenger; Tumor Cells, Cultured | 1993 |
Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cyclosporine; Drug Resistance; Humans; Liver Neoplasms; Tamoxifen; Tumor Cells, Cultured; Verapamil | 1993 |
Unique triple malignancies following renal transplantation.
Topics: Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Cholangiocarcinoma; Cyclosporine; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Neoplasms; Middle Aged; Postoperative Complications; Prednisolone; Retrospective Studies | 1996 |
Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%.
Topics: Carcinoma, Hepatocellular; Cyclosporine; Humans; Lipoproteins, LDL; Liver Neoplasms; Receptors, LDL; RNA, Messenger; Tumor Cells, Cultured | 1996 |
Scintigraphic detection of a disseminated synovial lymphoma in a postrenal transplant patient.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Cyclosporine; Female; Gallium Radioisotopes; Humans; Immunosuppressive Agents; Joint Diseases; Kidney Transplantation; Knee Joint; Liver Neoplasms; Lymphoma; Neoplasm Staging; Prednisone; Radionuclide Imaging; Synovial Membrane | 1996 |
Hepatitis B recurrence in relation to immunosuppression and acute allograft rejection.
Topics: Acute Disease; Carcinoma, Hepatocellular; Cause of Death; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Neoplasms; Liver Transplantation; Recurrence; Retrospective Studies | 1996 |
Long-term follow-up in hepatitis C patients with respect to immunosuppression.
Topics: Carcinoma, Hepatocellular; Cyclosporine; Graft Rejection; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Neoplasms; Liver Transplantation; Postoperative Complications; Recurrence; Retrospective Studies; Survival Rate; Tacrolimus | 1996 |
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation.
Topics: Carcinoma, Hepatocellular; Cyclosporine; Follow-Up Studies; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoma; Neoplasms; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 1996 |
Acute renal failure complicating liver transplantation in twin sisters with glycogen storage disease type Ia.
Topics: Acute Kidney Injury; Adenoma; Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Creatinine; Cyclosporine; Diseases in Twins; Female; Glycogen Storage Disease Type I; Hemofiltration; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Postoperative Complications; Twins, Monozygotic | 1996 |
Immune-cell system provides the development of extraneural tumors in the ethyl-nitrosourea model of neurocarcinogenesis.
Topics: Animals; Brain Neoplasms; Cyclosporine; Ethylnitrosourea; Immunosuppressive Agents; Kidney Neoplasms; Liver Neoplasms; Male; Neoplasms, Experimental; Neurilemmoma; Oligodendroglioma; Rats; Rats, Wistar | 1998 |
Different effects of cyclosporine or tacrolimus on hepatocyte acute phase proteins.
Topics: Acute-Phase Proteins; Carcinoma, Hepatocellular; Cell Survival; Cyclosporine; Humans; Immunosuppressive Agents; L-Lactate Dehydrogenase; Liver; Liver Neoplasms; Serum Albumin; Tacrolimus; Transferrin; Tumor Cells, Cultured | 1998 |
Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen.
Topics: Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Monitoring, Immunologic; Neoplasms, Second Primary; Opportunistic Infections; Postoperative Complications; Retrospective Studies | 1998 |
Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy.
Topics: Antigens, CD; CD4-CD8 Ratio; Cyclosporine; Follow-Up Studies; Hepatitis B; HLA-DR Antigens; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Lymphocyte Subsets; Postoperative Complications; Recurrence; Retrospective Studies; Tacrolimus; Time Factors | 1998 |
Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cyclosporine; Cyclosporins; Doxorubicin; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation | 1996 |
Tumor necrosis factor-alpha production by human hepatoma cell lines is resistant to drugs that are inhibitory to macrophages.
Topics: Adjuvants, Immunologic; Carcinoma, Hepatocellular; Cyclosporine; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Macrophages; Pentoxifylline; Pregnanes; Taurine; Thalidomide; Thiadiazines; Tumor Necrosis Factor-alpha | 1998 |
Ethanol potentiates tumor necrosis factor-alpha cytotoxicity in hepatoma cells and primary rat hepatocytes by promoting induction of the mitochondrial permeability transition.
Topics: Animals; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Survival; Cyclosporine; Cytochrome c Group; Cytochrome P-450 CYP2E1; Drug Synergism; Ethanol; Humans; Liver; Liver Neoplasms; Male; Mitochondria, Liver; Permeability; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells.
Topics: 4-Nitroquinoline-1-oxide; ATP Binding Cassette Transporter, Subfamily B; Carcinogens; Carcinoma, Hepatocellular; Cell Division; Cyclosporine; Drug Resistance, Neoplasm; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Inactivation, Metabolic; Isoenzymes; Liver Neoplasms; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Protein Isoforms; Sulfinpyrazone; Transfection; Tumor Cells, Cultured | 2000 |
Superoxide radical-initiated apoptotic signalling pathway in selenite-treated HepG(2) cells: mitochondria serve as the main target.
Topics: Acetylcysteine; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Caspase Inhibitors; Caspases; Cyclic N-Oxides; Cyclosporine; Cytochrome c Group; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Glutathione; Humans; In Situ Nick-End Labeling; Kinetics; Liver Neoplasms; Membrane Potentials; Mitochondria; Signal Transduction; Sodium Selenite; Spin Labels; Superoxides; Trifluoperazine; Tumor Cells, Cultured | 2001 |
[Cyclosporin A, renal transplant and hepatocarcinoma].
Topics: Carcinoma, Hepatocellular; Cyclosporine; Fatal Outcome; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Neoplasms; Male; Middle Aged | 2000 |
Combined liver and pancreatic islets transplantation in man using cyclosporin immunosuppression.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Insulin; Islets of Langerhans Transplantation; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Time Factors; Treatment Outcome | 1994 |
Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid.
Topics: Acetylcysteine; Apoptosis; Caprylates; Carcinogens; Carcinoma, Hepatocellular; Caspase 9; Caspases; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; Fluorocarbons; Humans; Hydrogen Peroxide; Kinetics; Liver Neoplasms; Membrane Potentials; Mitochondria, Liver; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured | 2001 |
Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Hepatocellular; Cyclosporine; Doxorubicin; Drug Resistance; Drug Synergism; Humans; Liver Neoplasms; RNA, Messenger; Tumor Cells, Cultured | 2001 |
Metabolism of an oxysterol, 7-ketocholesterol, by sterol 27-hydroxylase in HepG2 cells.
Topics: Cholestanetriol 26-Monooxygenase; Cholesterol; Chromatography, Gas; Chromatography, High Pressure Liquid; Cyclosporine; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Hepatoblastoma; Humans; Ketocholesterols; Liver Neoplasms; Mitochondria, Liver; Steroid Hydroxylases; Tumor Cells, Cultured | 2001 |
Human resistance artery reactivity is altered by liver transplantation and treatment with cyclosporin A.
Topics: Adipose Tissue; Angiotensin II; Arginine Vasopressin; Arteries; Cyclosporine; Humans; In Vitro Techniques; Liver Neoplasms; Liver Transplantation; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Vascular Resistance; Vasoconstriction | 1992 |
Non-Hodgkin lymphoma in the porta hepatis after orthotopic liver transplantation: sonographic findings.
Topics: Common Bile Duct; Cyclosporine; Hepatic Artery; Humans; Immunosuppression Therapy; Liver; Liver Neoplasms; Liver Transplantation; Lymphoma, B-Cell; Male; Middle Aged; Ultrasonography | 1992 |
Dormant liver metastases: an experimental study.
Topics: Animals; Cell Line; Colorectal Neoplasms; Cyclosporine; Hepatectomy; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Time Factors | 1992 |
Modulation of metabolism in HepG2 cells upon treatment with cyclosporin A and Nva2-cyclosporin.
Topics: Carcinoma, Hepatocellular; Carnitine O-Acetyltransferase; Catalase; Cholesterol; Cyclosporine; Cyclosporins; Dihydrolipoamide Dehydrogenase; Dolichols; Electron Transport Complex IV; Fatty Acid Desaturases; Glutathione Transferase; Humans; In Vitro Techniques; Lipid Metabolism; Liver Neoplasms; Microscopy, Electron; NADH Dehydrogenase; Palmitoyl Coenzyme A; Proteins; Time Factors; Tumor Cells, Cultured | 1991 |